Skip to main content
. 2014 Jul 12;165(4):690–696. doi: 10.1016/j.jpeds.2014.05.054

Table III.

Characteristics of the 100 infants who had a sepsis evaluation, antibiotic therapy initiated, and a respiratory viral PCR test performed in the NICU

Respiratory virus detection
Yes No P value
No. of infants 8 (8%) 92 (92%) -
GA, wk, median (IQR) 28 (26-33) 30 (27-36) .15
Birth weight, g median (IQR) 1025 (795-1240) 1424 (918-2388) .06
Age at sepsis evaluation, d median (IQR) 41 (26-57) 11 (7-22) .007
Weight at sepsis evaluation, g median (IQR) 2143 (1503-2619) 1671 (1055-2729) .4
Exposure to individuals with respiratory viral symptoms 3 (37%) 2 (2%) .003
T instability
 Hypothermia (T ≤36°C) 2 (25%) 14 (15%) .6
 Fever (T ≥38°C) 1 (12%) 6 (6%) .4
Apnea 6 (75%) 42 (46%) .14
Respiratory signs
 Any 7 (87%) 79 (86%) 1
 Tachypnea 6 (75%) 71 (72%) 1
 Retractions 6 (75%) 51 (55%) .5
 Rhinorrhea 2 (25%) 1 (1%) .02
 Congestion 2 (25%) 1 (1%) .02
 Cough 1 (12%) 2 (2%) .2
Increased or need for oxygen 7 (87%) 57 (62%) .2
Maximum respiratory support 7 (87%) 60 (64%) .2
 Nasal cannula 4 (57%) 15 (25%) .1
 CPAP 0 22 (37%) .08
 Mechanical ventilation 3 (43%) 23 (37%) 1
 Duration, d, mean (±SD) 3.7 (±3) 6.9 (±6.5) .4
Gastrointestinal signs
 Any 4 (50%) 41 (43%) 1
 Feeding intolerance 2 (25%) 31 (37%) 1
 Emesis 1 (12%) 21 (23%) .7
 Diarrhea 0 1 (1%) 1
 Abdominal distension 0 29 (31%) .1
 Hematochezia 2 (25%) 8 (9%) .2
Hypotension 0 10 (11%) 1
 Fluid bolus (saline; intravenous) 0 10 (11%) 1
 Inotropic agents 0 5 (5%) 1
Neurologic signs
 Any 0 18 (20%) .2
 Lethargy 0 10 (11%) 1
 Hypotonia 0 9 (10%) 1
 Irritability 0 4 (4%) 1
Hematologic values
 White cell blood count, cells/mL, median (IQR) 9785 (5600-12 250) 11 535 (8740-16 288) .19
 Absolute total neutrophils, cells/mL, median (IQR) 1790 (1232-4418) 4530 (2850-7871) .02
 Lymphocytes, cells/mL, median (IQR) 5124 (3304-5412) 4120 (2665-5715) .5
 Platelets, no./mL, median (IQR) 265 000 (117 250-389 250) 265 000 (145 000-363 000)§ .9
 Hemoglobin, g/dL, median (IQR) 10.3 (9.4-12.8) 11.8 (10.1-13.7) .3
 Hematocrit, %, median (IQR) 30 (28-37) 35 (30-41) .3
Bacterial coinfection
 Urine culture positive 1/7 (14%) 9/71 (13%) 1
 Blood culture positive 0 15 (16%)∗∗ .6
Duration of hospitalization, d, mean (±SD) 84 (±48) 68 (±43) .3
Bronchopulmonary dysplasia
 Any 3 (37%) 25 (27%) .7
 Mild 1 (33%) 9 (36%) 1
 Moderate 0 2 (8%) 1
 Severe 2 (67%) 14 (56%) 1
No. of infants who had respiratory viral testing performed by provider 6 (75%) 10 (11%)†† .001
Antibiotic duration, d median (IQR) 6.5 (2.2-7.7) 3 (2-7) .3
Death 0 4 (4%) 1

CPAP, continuous positive airway pressure; T, temperature.

Significant P values (< .05) are represented in bold.

Contacts were parents, grandparents, and nurse.

Contacts were mother and siblings.

Performed on 7 and 91 infants with and without viral detection, respectively.

§

Performed on 91 infants without viral detection.

1, coagulase-negative staphylococcus (3 × 104 colonies/mL) by suprapubic aspiration.

3, Enterococcus faecalis (>2 × 104 colonies/mL by catheterization); 1, Enterobacter cloacae (>104 colonies/mL) by catheterization; 1, Klebsiella pneumoniae (104 colonies/mL) by catheterization; 1, coagulase-negative staphylococcus (3 × 104 colonies/mL) by suprapubic aspiration; 1, Escherichia coli (105 colonies/mL) by suprapubic aspiration; 1, K pneumoniae (8 × 103 colonies/mL) and E faecalis (6 × 103 colonies/mL) by suprapubic aspiration; 1, Enterococcus sp. and Klebsiella oxytoca (collection method and colony counts not known).

∗∗

2, K oxytoca; 3, K pneumoniae; 6, coagulase-negative staphylococci; 1, Enterobacter aerogenes; 1, E coli; 1, E faecalis; 1, group B Streptococcus.

††

All 10 infants had negative respiratory viral testing results at birth hospital.